Lung cancer (respiratory medicine)

Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [¹⁸F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT
Salvatore Cappabianca, Annamaria Porto, Mario Petrillo, Barbara Greco, Alfonso Reginelli, Francesco Ronza, Francesca Setola, Giovanni Rossi, Andrea Di Matteo, Roberto Muto, Maria Luisa De Rimini, Sergio Piccolo, Mara Catalano, Pietro Muto, Nicoletta De Rosa, Enrica Barra, Ilaria De Rosa, Francesca Antinolfi, Giuseppe Antinolfi, Mario Caputi, Luca Brunese, Roberto Grassi, Antonio Rotondo

Journal of Clinical Pathology Feb 2011, 64 (2) 114-119; DOI: 10.1136/jcp.2010.076562
An uncommon pattern of cardiac invasion in hepatocellular carcinomaHCC, hepatocellular carcinoma
E Anton, A Astiazaran

Journal of Clinical Pathology Dec 2006, 59 (12) 1337; DOI: 10.1136/jcp.2005.035238
Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer
T Leinonen, R Pirinen, J Böhm, R Johansson, A Rinne, E Weber, V-M Kosma

Journal of Clinical Pathology May 2007, 60 (5) 515-519; DOI: 10.1136/jcp.2006.038711
Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis
Riku Turkki, Nina Linder, Tanja Holopainen, Yinhai Wang, Anne Grote, Mikael Lundin, Kari Alitalo, Johan Lundin

Journal of Clinical Pathology Aug 2015, 68 (8) 614-621; DOI: 10.1136/jclinpath-2015-202888
Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer
P Y Yip, W A Cooper, M R J Kohonen-Corish, B P C Lin, B C McCaughan, M J Boyer, J G Kench, L G Horvath

Journal of Clinical Pathology Apr 2014, 67 (4) 333-340; DOI: 10.1136/jclinpath-2013-201870
Detection of the CD56+/CD45− immunophenotype by flow cytometry in neuroendocrine malignancies
G J Bryson, D Lear, R Williamson, R C W Wong

Journal of Clinical Pathology Jul 2002, 55 (7) 535-537;
Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer
K Okada, T Hasegawa, R Yokoyama, Y Beppu, E Itoi

Journal of Clinical Pathology Oct 2003, 56 (10) 742-746; DOI: 10.1136/jcp.56.10.742
Thyroid transcription factor 1 in pulmonary adenocarcinoma
G Stenhouse, N Fyfe, G King, A Chapman, K M Kerr

Journal of Clinical Pathology Apr 2004, 57 (4) 383-387; DOI: 10.1136/jcp.2003.007138
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma
W A Cooper, B Yu, P Y Yip, C C Ng, T Lum, M Farzin, R J Trent, B Mercorella, A Clarkson, M R J Kohonen-Corish, L G Horvath, J G Kench, B McCaughan, A J Gill, S A O'Toole

Journal of Clinical Pathology Sep 2013, 66 (9) 744-748; DOI: 10.1136/jclinpath-2013-201607
Reduced expression of α-catenin, β-catenin, and γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer
R T Pirinen, P Hirvikoski, R T Johansson, S Hollmén, V-M Kosma

Journal of Clinical Pathology May 2001, 54 (5) 391-395; DOI: 10.1136/jcp.54.5.391

Main menu

Lung cancer (respiratory medicine)

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Lung cancer (respiratory medicine)

Pages